Corporate interest in cryptocurrencies is intensifying as firms look beyond the dominance of Bitcoin and Ethereum in their treasury strategies. Solana has become the standout option, rapidly gaining traction among companies eager to diversify into digital assets with strong growth potential. The latest addition to this trend is Helius Medical Technologies, a Nasdaq-listed company that […] Continue Reading: Another Nasdaq Firm Bets Big on Solana – $500 in Sight?Corporate interest in cryptocurrencies is intensifying as firms look beyond the dominance of Bitcoin and Ethereum in their treasury strategies. Solana has become the standout option, rapidly gaining traction among companies eager to diversify into digital assets with strong growth potential. The latest addition to this trend is Helius Medical Technologies, a Nasdaq-listed company that […] Continue Reading: Another Nasdaq Firm Bets Big on Solana – $500 in Sight?

Another Nasdaq Firm Bets Big on Solana – $500 in Sight?

2025/09/27 03:31
1 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
Corporate interest in cryptocurrencies is intensifying as firms look beyond the dominance of Bitcoin and Ethereum in their treasury strategies. Solana has become the standout option, rapidly gaining traction among companies eager to diversify into digital assets with strong growth potential. The latest addition to this trend is Helius Medical Technologies, a Nasdaq-listed company that […]

Continue Reading: Another Nasdaq Firm Bets Big on Solana – $500 in Sight?

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.